PARSIPPANY, New Jersey, January 10, 2011 /PRNewswire/ -- As Ogilvy CommonHealth Worldwide, the largest healthcare communications network, formally opens its doors for business, the company has released the results of a global survey of pharmaceutical executives identifying predictions for healthcare marketing communications in 2011. As might be expected, the survey revealed a continued shift toward digital communications, with 74% of respondents anticipating an increased spend on digital activities in the coming year. Other key survey findings include the changing role of the patient and a trend toward more customer segmentation. The survey, which interviewed pharmaceutical executives from 57 countries, all with responsibilities for marketing or communications, was conducted by FirstWord Pharma.
"As the world's largest and most extensive healthcare communications network, we are committed to anticipating changes within the healthcare industry, and enabling our clients to successfully navigate through a rapidly evolving healthcare environment," said Matt Giegerich, Chairman and CEO of Ogilvy CommonHealth Worldwide. "While the survey revealed what we expected it would about the growing role of digital technologies in healthcare, it is crucial to remember that technology in itself is not a panacea; it needs to be adopted and incorporated into our everyday behavior."
Anticipating the role digital communications will continue to have on healthcare communications, Ogilvy CommonHealth Worldwide has published 202020 VISION, a digital-health report outlining 20 scenarios of what digitally driven healthcare might look like in 2020.
"In our view, technology, particularly that which has driven social media, already has had a profound impact on the psychosocial context of health and healthcare," said David Davenport-Firth, global brand strategy director and author of 202020 VISION. "And this will continue at an accelerating pace up to and beyond 2020."
For more information about Ogilvy CommonHealth Worldwide and to see the results of the global survey of pharmaceutical executives, visit
To request a copy of 202020 VISION, please contact 202020@ogilvy.com.
Notes to Editors:
Comments